A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

C.A. Rentsch; G.N. Thalmann; I. Lucca; M. Kwiatkowski; G.J. Wirth; R.T. Strebel; D. Engeler; A. Pedrazzini; C. Hüttenbrink; W. Schultze-Seemann; R. Torpai; L. Bubendorf; A. Wicki; B. Roth; P. Bosshard; H. Püschel; D.T. Boll; L. Hefermehl; F. Roghmann; M. Gierth; K. Ribi; S. Schäfer; S. Hayoz

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

C.A. Rentsch
, G.N. Thalmann
, I. Lucca
, M. Kwiatkowski
, G.J. Wirth
, R.T. Strebel
, D. Engeler
, A. Pedrazzini
, C. Hüttenbrink
, W. Schultze-Seemann
, R. Torpai
, L. Bubendorf
, A. Wicki
, B. Roth
, P. Bosshard
, H. Püschel
, D.T. Boll
, L. Hefermehl
, F. Roghmann
, M. Gierth

K. Ribi, S. Schäfer, S. Hayoz

Careum School of Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	195-202
Number of pages	8
Journal	European urology oncology
Volume	5
Issue number	2
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Rentsch, C. A., Thalmann, G. N., Lucca, I., Kwiatkowski, M., Wirth, G. J., Strebel, R. T., Engeler, D., Pedrazzini, A., Hüttenbrink, C., Schultze-Seemann, W., Torpai, R., Bubendorf, L., Wicki, A., Roth, B., Bosshard, P., Püschel, H., Boll, D. T., Hefermehl, L., Roghmann, F., ... Hayoz, S. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European urology oncology, 5(2), 195-202.

@article{7914da1de90f4d1fb7a974f16cf1dd12,

title = "A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Gu{\'e}rin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14",

author = "C.A. Rentsch and G.N. Thalmann and I. Lucca and M. Kwiatkowski and G.J. Wirth and R.T. Strebel and D. Engeler and A. Pedrazzini and C. H{\"u}ttenbrink and W. Schultze-Seemann and R. Torpai and L. Bubendorf and A. Wicki and B. Roth and P. Bosshard and H. P{\"u}schel and D.T. Boll and L. Hefermehl and F. Roghmann and M. Gierth and K. Ribi and S. Sch{\"a}fer and S. Hayoz",

year = "2022",

language = "English",

volume = "5",

pages = "195--202",

journal = "European urology oncology",

number = "2",

}

Rentsch, CA, Thalmann, GN, Lucca, I, Kwiatkowski, M, Wirth, GJ, Strebel, RT, Engeler, D, Pedrazzini, A, Hüttenbrink, C, Schultze-Seemann, W, Torpai, R, Bubendorf, L, Wicki, A, Roth, B, Bosshard, P, Püschel, H, Boll, DT, Hefermehl, L, Roghmann, F, Gierth, M, Ribi, K, Schäfer, S & Hayoz, S 2022, 'A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14', European urology oncology, vol. 5, no. 2, pp. 195-202.

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. / Rentsch, C.A.; Thalmann, G.N.; Lucca, I. et al.
In: European urology oncology, Vol. 5, No. 2, 2022, p. 195-202.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

AU - Rentsch, C.A.

AU - Thalmann, G.N.

AU - Lucca, I.

AU - Kwiatkowski, M.

AU - Wirth, G.J.

AU - Strebel, R.T.

AU - Engeler, D.

AU - Pedrazzini, A.

AU - Hüttenbrink, C.

AU - Schultze-Seemann, W.

AU - Torpai, R.

AU - Bubendorf, L.

AU - Wicki, A.

AU - Roth, B.

AU - Bosshard, P.

AU - Püschel, H.

AU - Boll, D.T.

AU - Hefermehl, L.

AU - Roghmann, F.

AU - Gierth, M.

AU - Ribi, K.

AU - Schäfer, S.

AU - Hayoz, S.

PY - 2022

Y1 - 2022

M3 - Article

VL - 5

SP - 195

EP - 202

JO - European urology oncology

JF - European urology oncology

IS - 2

ER -